- Home
- RAYA vs ANEB Comparison
RAYA vs ANEB Comparison
Compare RAYA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- ANEB
- Stock Information
- Founded
- RAYA 2019
- ANEB 2020
- Country
- RAYA China
- ANEB United States
- Employees
- RAYA N/A
- ANEB N/A
- Industry
- RAYA Metal Fabrications
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- RAYA Consumer Discretionary
- ANEB Health Care
- Exchange
- RAYA Nasdaq
- ANEB Nasdaq
- Market Cap
- RAYA 5.2M
- ANEB 111.8M
- IPO Year
- RAYA 2022
- ANEB 2021
- Fundamental
- Price
- RAYA $5.05
- ANEB $2.76
- Analyst Decision
- RAYA
- ANEB Buy
- Analyst Count
- RAYA 0
- ANEB 2
- Target Price
- RAYA N/A
- ANEB $8.00
- AVG Volume (30 Days)
- RAYA 198.0K
- ANEB 25.7K
- Earning Date
- RAYA 01-01-0001
- ANEB 11-12-2025
- Dividend Yield
- RAYA N/A
- ANEB N/A
- EPS Growth
- RAYA N/A
- ANEB N/A
- EPS
- RAYA N/A
- ANEB N/A
- Revenue
- RAYA $30,300,360.00
- ANEB N/A
- Revenue This Year
- RAYA $20.95
- ANEB N/A
- Revenue Next Year
- RAYA N/A
- ANEB N/A
- P/E Ratio
- RAYA N/A
- ANEB N/A
- Revenue Growth
- RAYA 49.10
- ANEB N/A
- 52 Week Low
- RAYA $3.65
- ANEB $0.80
- 52 Week High
- RAYA $737.00
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- RAYA 54.56
- ANEB 64.17
- Support Level
- RAYA $4.69
- ANEB $2.50
- Resistance Level
- RAYA $5.17
- ANEB $2.76
- Average True Range (ATR)
- RAYA 0.58
- ANEB 0.12
- MACD
- RAYA -0.29
- ANEB 0.03
- Stochastic Oscillator
- RAYA 8.47
- ANEB 85.00
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.